Alnylam Pharmaceuticals logo

Alnylam Pharmaceuticals Employee Directory

Biotechnology ResearchMassachusetts, United States1001-5000 Employees

Alnylam Pharmaceuticals, based in Cambridge, Massachusetts, is an independent biopharmaceutical company focused on RNA interference (RNAi) therapeutics. It aims to silence disease-causing genes to treat a range of conditions, including both rare and prevalent diseases, with its first RNAi therapy approved in 2018. The company operates on a global scale with offices across North America, Europe, Asia, and South America and an international workforce. Its products are designed for patients and the healthcare system, and the company pursues partnerships to broaden access, including a June 2026 expansion of its collaboration with Genesis Pharma Group in Europe. Within the biotech industry, Alnylam is positioned as a pioneer in RNAi therapeutics, continuing development across indications and maintaining active engagement in the field.

Find Alnylam Pharmaceuticals employees' phone numbers or email addresses

Alnylam Pharmaceuticals Global Highlights

Location
Employees

North America
2.8K

Minus sign iconPlus sign icon
  • United States Of America
    2.7K
  • Canada
    16
  • Mexico
    1
  • Haiti
    1

Europe
456

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    144
  • Switzerland
    60
  • Netherlands
    58
  • Germany
    56
  • Spain
    39
  • Italy
    38
  • France
    30
  • Portugal
    9
  • Sweden
    7
  • Austria
    6
  • Belgium
    3
  • Greece
    1
  • Cyprus
    1
  • Ireland
    1
  • Poland
    1
  • Denmark
    1
  • Luxembourg
    1

Asia
53

Minus sign iconPlus sign icon
  • Japan
    37
  • India
    11
  • Saudi Arabia
    2
  • Jordan
    1
  • Iran
    1
  • United Arab Emirates
    1

South America
26

Minus sign iconPlus sign icon
  • Brazil
    26

Africa
4

Minus sign iconPlus sign icon
  • Egypt
    3
  • Nigeria
    1

Alnylam Pharmaceuticals's Leadership

  • Stylized image of a person
    D. C.
    Chief Executive Officer
  • Stylized image of a person
    V. R.
    Chief Financial Officer
  • Stylized image of a person
    D. J.
    Chief Financial Officer
  • Stylized image of a person
    D. Q.
    Chief Financial Officer
  • Stylized image of a person
    J. H.
    Chief Operating Officer
  • Stylized image of a person
    L. M.
    Chief Of Staff To The Chro And Hr Business Partner
  • Stylized image of a person
    P. H.
    Chief Ethics & Compliance Officer
  • Stylized image of a person
    S. C.
    Chief Technology Officer

Alnylam Pharmaceuticals Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Business
  • Operations
  • Engineering
  • Analytics
  • Other
  • Quality Assurance
  • Biotechnology
  • Sales
  • Legal
  • Administrative
  • Community & Social Services

Contact profiles from Alnylam Pharmaceuticals

Name
Title
Contact
Location
Last Update
  • Stylized image of a person
    S. P.
    Owner
    Oct 17, 2024
  • Stylized image of a person
    V.
    President
    Sep 23, 2024
  • Stylized image of a person
    M. L.
    Vp - Clinical Research
    United Kingdom
    May 28, 2026
  • Stylized image of a person
    T. P.
    International Market Access, Pricing & Policy Lead (head Of International Market Access)
    Switzerland
    May 07, 2026
  • Stylized image of a person
    M. B.
    Vp, Head Of Regional Commercial Ttr Amyloidosis
    SwitzerlandCanton of Zug
    May 06, 2026
  • Stylized image of a person
    D. C.
    Vice President, Business Operations International
    United KingdomEngland
    Apr 16, 2026
  • Stylized image of a person
    T. G.
    North America Head Of Sales
    Jul 27, 2026
  • Stylized image of a person
    F. E. V. M. P. M.
    Senior Vice President, Head Of Global Patient Safety & Risk Management
    SwitzerlandCanton of Zug
    Jun 29, 2026
  • Stylized image of a person
    P. N.
    Senior Vice President, Research
    United Kingdom
    Apr 28, 2026
  • Stylized image of a person
    C. O.
    Head Of Privacy - Global
    SpainCatalonia
    Feb 18, 2026

Frequently Asked Questions

What is Alnylam Pharmaceuticals known for?

Minus sign iconPlus sign icon
Alnylam Pharmaceuticals was founded in 2002 operates in the Biotechnology Research industry; you can contact the main corporate office by phone at . Explore Alnylam Pharmaceuticals's company overview page for more information.

What is Alnylam Pharmaceuticals's most common email format?

Minus sign iconPlus sign icon
Alnylam Pharmaceuticals employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Alnylam Pharmaceuticals email formats with LeadIQ.

How many employees does Alnylam Pharmaceuticals have currently?

Minus sign iconPlus sign icon
Alnylam Pharmaceuticals has approximately 2.9K employees as of July 2026. These team members are located across 5 continents, including North AmericaEuropeAsia.

Who are Alnylam Pharmaceuticals's key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, Alnylam Pharmaceuticals's key employees include:

  • Chief Executive Officer: D. C.
  • Chief Financial Officer: V. R.
  • Chief Financial Officer: D. J.
  • Chief Financial Officer: D. Q.
  • Chief Operating Officer: J. H.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.